(309 days)
The Ambu® Blue Sensor NEO and Ambu® Blue Sensor NEO X electrodes are made for ECG monitoring of neonatal and paediatric patients. The ECG electrodes are applied to the surface of the body to transmit the electrical signal at the body surface to a processor that produces an electrocardiogram or vectorcardiogram. The electrodes are for single patient use only.
Ambu® Blue Sensor NEO/NEO X is non-sterile, self-adhesive ECG electrodes. Ambu® Blue Sensor NEO/NEO X should only be used by or on the order of a physician. Ambu® Blue Sensor NEO/NEO X is single patient use disposable devices. Ambu® Blue Sensor NEO/NEO X is a multi-layer construction containing a pre-attached lead wire with an attached connector, a top disc, a top film, a sensor and a hydrogel adhesive.
The provided text describes the 510(k) summary for the Ambu® Blue Sensor NEO/NEO X disposable ECG electrodes. Here's a breakdown of the acceptance criteria and study information:
1. Table of acceptance criteria and the reported device performance
| Acceptance Criteria | Reported Device Performance |
|---|---|
| Electrical and mechanical functionality required by ANSI/AAMI EC12:2000 - Disposable ECG Electrodes | The Ambu® Blue Sensor NEO/NEO X meets the mandatory performance standard requirements under ANSI/AAMI EC12:2000. |
| Biocompatibility as per ISO 10993-1 – Biological evaluation of Medical Devices | The biological safety of the Ambu® Blue Sensor NEO/NEO X has been assured through the selection of materials demonstrating appropriate levels of biocompatibility. The biocompatibility has been established. |
| Equivalent electrical and mechanical functionality to predicate devices (Ambu® Blue Sensor NF and Ambu® Blue Sensor BRS) | Aging tests and comparison tests to predicate devices were performed, concluding that the Ambu® Blue Sensor NEO/NEO X has equivalent electrical and mechanical functionality to the predicate devices. |
2. Sample size used for the test set and the data provenance
- Sample Size: The document does not specify a distinct "test set" sample size in terms of the number of electrodes or the duration of testing for the acceptance criteria outlined. It mentions "laboratory tests" and "aging test."
- Data Provenance: The tests conducted are non-clinical laboratory tests performed by the manufacturer, Ambu A/S, in Denmark. The data is prospective in the sense that it was generated specifically for this 510(k) submission.
3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts
- Not applicable. This device is a disposable ECG electrode, not an AI/software device that requires expert ground truth for interpretation of diagnostic images or signals. The "ground truth" for its performance is derived from compliance with engineering standards (ANSI/AAMI EC12:2000) and biocompatibility standards (ISO 10993-1).
4. Adjudication method (e.g., 2+1, 3+1, none) for the test set
- Not applicable. As above, this is not an AI/software device requiring subjective interpretation or adjudication of results. Compliance with standards is objective.
5. If a multi-reader multi-case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance
- No, an MRMC comparative effectiveness study was not done. This is a hardware device (ECG electrode), not an AI assistance tool for human readers.
6. If a standalone (i.e., algorithm only without human-in-the-loop performance) was done
- Not applicable. This is a hardware device, not an algorithm.
7. The type of ground truth used (expert consensus, pathology, outcomes data, etc.)
- The "ground truth" for this device's performance is established by engineering standards (ANSI/AAMI EC12:2000) for electrical and mechanical functionality and biocompatibility standards (ISO 10993-1) for material safety.
8. The sample size for the training set
- Not applicable. This is a hardware device, not a machine learning model that requires a training set.
9. How the ground truth for the training set was established
- Not applicable. As this is a hardware device, there is no "training set" in the context of machine learning.
{0}------------------------------------------------
510(k) Summary
OCT 2 5 2006
- 510(k) owner: Ambu A/S Baltorpbakken 13 2750 Ballerup Denmark Tel.: +45 72252000 Fax.: +45 72252050
Contact person: Laila Strange Lundtoft Regulatory Affairs Manager
-
- December 2005 2. Preparation date of the 510(k) summary:
| 3. Name of device:Device Common name: | Disposable ECG electrode |
|---|---|
| Device Trade name: | Ambu® Blue Sensor NEOAmbu® Blue Sensor NEO X |
| Classification Name: | Electrode, Electrocardiograph.21 CFR 870.2360 |
| Product Code: | DRX |
-
- Identifies the legally marketed device to which equivalence is claimed
| Manufacturer | Trade Name | Productcode |
|---|---|---|
| Ambu A/S | Ambu® Blue Sensor NF | DRX |
| Ambu A/S | Ambu® Blue Sensor BRS | DRX |
E-1
Page 1 of 2
{1}------------------------------------------------
5. Description of device
Ambu® Blue Sensor NEO/NEO X is non-sterile, self-adhesive ECG electrodes. Ambu® Blue Sensor NEO/NEO X should only be used by or on the order of a physician.
Ambu® Blue Sensor NEO/NEO X is single patient use disposable devices.
Ambu® Blue Sensor NEO/NEO X is a multi-layer construction containing a pre-attached lead wire with an attached connector, a top disc, a top film, a sensor and a hydrogel adhesive.
-
- The intended use
Ambu® Blue Sensor NEO/NEO X is for ECG monitoring of Neonatal and Paediatric care.
- The intended use
-
- Summary of the technological Characteristics The technological characteristics of Ambu® Blue Sensor NEO/NEO X are identical to the predicate devices. Ambu® Blue Sensor NEO/NEO X is a multi-layer construction containing a pre-attached lead wire with an attached connector, a top disc, a top film, a sensor and a hydrogel adhesive.
-
- Brief discussion of the nonclinical tests submitted The non-clinical tests performed are laboratory tests to ensure the electrical and mechanical functionality of the electrode meets the standard ANSI/AAMI EC12:2000 - Disposable ECG Electrodes.
-
- Brief discussion of the clinical tests submitted No clinical tests are performed
-
10.Biocompatibility testing
The biological safety of the Ambu® Blue Sensor NEO/NEO X has been assured through the selection of materials which demonstrate appropriate levels of biocompatibility. Tests were selected on the basis of ISO 10993-1 – Biological evaluation of Medical Devices.
11.Conclusions drawn from the nonclinical, clinical and biocompatibility tests Aging test of Ambu® Blue Sensor NEO/NEO X and comparison test to predicate devices have been performed. From the results it has been concluded that the Ambu® Blue Sensor NEO/NEO X have equivalent electrical and mechanical functionality as the predicate devices.
The Ambu® Blue Sensor NEO/NEO X meet the mandatory performance standard requirements under ANSI/AAMI EC12:2000 ~ Disposable ECG electrodes.
The biocompatibility of the Ambu® Blue Sensor NEO/NEO X have been established.
It is concluded that Ambu® Blue Sensor NEO/NEO X are safe and effective electrodes and comparable to the predicate devices.
F-2
Page 2 of 2
{2}------------------------------------------------
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
OCT 25 2006
Ambu Inc. c/o Mr. Sanjay Parikh Technical and Regulatory Affairs 6740 Baymeadow Dr. Glen Burnie, MD 21060
Re: K053550
Trade Name: Ambu® Blue Sensor NEO & Ambu® Blue Sensor NEO-X Regulation Number: 21 CFR 870.2360 Regulation Name: Electrocardiograph Electrode Regulatory Class: II (two) Product Code: DRX Dated: October 10, 2006 Received: October 12, 2006
Dear Mr. Parikh:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
{3}------------------------------------------------
Page 2 - Mr. Sanjay Parikh
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (240) 276-0120. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.
Sincerely yours,
Bhimama for
Bram D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{4}------------------------------------------------
Indications for Use
510(k) Number (if known):
/1053550
Device Name: Ambu® Blue Sensor NEO and Ambu® Blue Sensor NEO X
Indications For Use:
The Ambu® Blue Sensor NEO and Ambu® Blue Sensor NEO X electrodes are made for ECG monitoring of neonatal and paediatric patients. The ECG electrodes are applied to the surface of the body to transmit the electrical signal at the body surface to a processor that produces an electrocardiogram or vectorcardiogram. The electrodes are for single patient use only.
Prescription Use x (Part 21 CFR 801 Subpart D)
AND/OR
Over-The-Counter Use (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Bhimma
(Division Sign-Off)
Division of Cardiovascular Devices
510(k) Number Kn53550
Page 1 of
§ 870.2360 Electrocardiograph electrode.
(a)
Identification. An electrocardiograph electrode is the electrical conductor which is applied to the surface of the body to transmit the electrical signal at the body surface to a processor that produces an electrocardiogram or vectorcardiogram.(b)
Classification. Class II (special controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 870.9. The special control for this device is the FDA guidance document entitled “Class II Special Controls Guidance Document: Electrocardiograph Electrodes.” See § 870.1(e) for availability information of guidance documents.